Loading...
•
Sep 30, 2023
biote Q3 2023 Earnings Report
Biote's revenue and Adjusted EBITDA grew, reflecting patient demand for hormone optimization and wellness therapies.
Key Takeaways
Biote reported an 8.5% increase in revenue to $45.6 million and a net income of $19.6 million for the third quarter of 2023. The company's Adjusted EBITDA increased by 14.7% to $14.0 million.
Revenue increased by 8.5% to $45.6 million.
Gross profit margin increased by 70 basis points to 68.9%.
Net income was $19.6 million, with earnings per share of $0.25.
Adjusted EBITDA increased by 14.7% to $14.0 million.
Forward Guidance
Biote anticipates that 2023 revenue and Adjusted EBITDA will likely be toward the lower end of the provided guidance range.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...